Login / Signup

Response to: Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Aznar et al.

Giorgio BoganiLuca LalliJvan CasarinFabio GhezziValentina ChiappaFrancesco FanfaniGiovanni ScambiaFrancesco Raspagliesi
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Keyphrases
  • endometrial cancer
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • lymph node
  • neoadjuvant chemotherapy
  • open label
  • radiation therapy
  • rectal cancer